BiomX: Of The Original Reports To Include (x) The Audited Consolidated Financial Statements Of As Of And For The Years Ended December31, 2025 And 2024 And (y) The Unaudited Condensed Financial Statements As Of And For The Three Months Ended March 31, 2026 And 2025 For Each Of Zorronet And Dfsl; And (ii)update The Information In Item 9.01(b) Of The Original Reports To Include The Unaudited Pro Forma Condensed Combined Financial Information Of The Company Reflecting The Acquisitions Of Zorronet And Dfsl As Of And For The Year Ended December31, 2025 And The Period Ended March 31, 2026, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  BiomX Inc.
• Paese di registrazione
  USA
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***